Home > News > Accelrys: A Solid Nanotech Investment
March 23rd, 2005
Accelrys: A Solid Nanotech Investment
Abstract:
Jack Uldrich: Last week, I advised my readers to stay away from two nanotechnology stocks that I consider wildly overvalued—Altair and Biophan. This week, I would like to highlight one that I consider undervalued and worthy of an investment—Accelrys (ACCL), which is trading at $5.12 a share. (Full disclosure: I own stock in Accelrys).
Source:
NanoNovus
Bookmark:
Investments/IPO's/Splits
Elsevier Business Intelligence (EBI) to Host 'IN3 Medical Device 360 Boston,' June 24-26, 2013 May 20th, 2013
Aspen Aerogels Announces $22.5 Million Private Placement May 18th, 2013
Harris & Harris Group Notes the Sale of a Second D-Wave Quantum Computer May 16th, 2013
Nanometrics Announces Upcoming Investor Events May 14th, 2013
Profiles
Russia’s Nano-enabled Products Market to Witness Massive Growth February 8th, 2011
Adept Technology Announces Orders for Over $600K from Chinese Partner January 18th, 2011
Nanostart-held ItN Nanovation Receives Major Follow-on Order in Saudi Arabia November 29th, 2010
Homegrown Companies Developing Batteries for Clean Energy Storage November 2nd, 2010